Intimation of date of the 45th Annual General Meeting and Record Date for payment of Final Dividend on Equity Shares for the Financial Year March 31, 2026

Emcure Ref: EPL/CS/SE/0068/2026 Date: August 06, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation of date of the 45th Annual General Meeting and Record Date for payment of Final Dividend on Equity Shares for the Financial Year ended March 31, 2026 We wish to inform you that the 45th Annual General Meeting (“AGM”) of the Members of the Company is scheduled to be held on Monday, September 21, 2026, at 11.00 a.m. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India, inter-alia, to transact the business(es) as set out in the Notice convening AGM. As earlier informed, the Board of Directors at its meeting held on Tuesday, May 05, 2026, had recommended Final Dividend of Rs. 3.60/- (Rupees Three and Sixty Paise only) per Equity Share of Rs. 10/- (Rupees Ten only) each of the Company (at the rate of 36%) for the Financial Year ended March 31, 2026. Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Record Date has been fixed as Friday, September 04, 2026, for determining entitlement of Members to Final Dividend for the Financial Year ended March 31, 2026. If the Final Dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to tax deduction at source (TDS) as per the provisions of the Income Tax Act, 1961 and the Rules framed thereunder, as amended by the Finance Act, 2020, shall be made within 30 days from the date of approval of the Members at the AGM as provided in the Companies Act, 2013. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer ICSI Membership Number: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251